سعر ليفوكسين 500مجم فيال 100 مل 2022

Levofloxacin 500 mg/100 mL (5 mg/mL) solution for intravenous infusion, 1 vial of 100 mL.

• Nosocomial pneumonia (adults).Population: AdultsDailyMed (U.S. National Library of Medicine)
• Community-acquired pneumonia (adults).Population: AdultsDailyMed (U.S. National Library of Medicine)
• Skin and skin structure infections, complicated and uncomplicated (adults).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common (at least 3%): nausea, headache, diarrhoea, insomnia, constipation and dizziness.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to levofloxacin or other quinolone antibacterials.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: fluoroquinolones are associated with disabling and potentially irreversible serious adverse reactions including tendinitis and tendon rupture, peripheral neuropathy and CNS effects - discontinue immediately if these occur; may exacerbate muscle weakness in myasthenia gravis (avoid); reserve for patients without alternative options for uncomplicated UTI, acute bacterial exacerbation of chronic bronchitis and acute bacterial sinusitis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Other warnings: hypersensitivity reactions (including anaphylaxis), hepatotoxicity, aortic aneurysm and dissection, Clostridioides difficile-associated diarrhoea, QT prolongation, blood glucose disturbances and photosensitivity/phototoxicity.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Multivalent cation-containing solutions (e.g. magnesium)Do not co-administer through the same intravenous line.DailyMed (U.S. National Library of Medicine)
• WarfarinEnhanced warfarin effect with bleeding has been reported; monitor prothrombin time/INR and for bleeding.DailyMed (U.S. National Library of Medicine)
• Antidiabetic agentsBlood glucose disturbances (hypo- and hyperglycaemia) have been reported; monitor blood glucose carefully.DailyMed (U.S. National Library of Medicine)

• The label states there are no adequate and well-controlled studies in pregnant women; levofloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus (not teratogenic in rats at oral doses up to 810 mg/kg/day).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Levofloxacin is presumed to be excreted in human milk; because of potential serious adverse reactions in nursing infants, decide whether to discontinue nursing or the drug.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Levofloxacin: Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV.